117 related articles for article (PubMed ID: 7041380)
41. Immunological features of preeclampsia: increased frequency of antilymphocyte antibodies, but not of immune complexes.
Mekori YA; Becker M; Moalem I; Schneider A; Bott G; Klajman A
Isr J Med Sci; 1981 Nov; 17(11):1051-5. PubMed ID: 7319793
[TBL] [Abstract][Full Text] [Related]
42. [Two solid-phase ELISAs for measuring circulating immune complexes in human sera].
Wahn V; Poleshuck L; Fogel M; Good RA; Day NK
Med Lab (Stuttg); 1981 Dec; 34(12):331-7. PubMed ID: 7050646
[No Abstract] [Full Text] [Related]
43. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
44. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
45. [Circulating immune complexes in the serum of tumor patients].
Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
[TBL] [Abstract][Full Text] [Related]
46. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
47. Immune complexes and complement components in Bell's palsy.
Jonsson L; Larsson A; Thomander L
ORL J Otorhinolaryngol Relat Spec; 1987; 49(6):294-301. PubMed ID: 3501560
[TBL] [Abstract][Full Text] [Related]
48. Astonished reader:description of a solid phase C1q enzyme assay for the detection of circulating immune complexes.
Ruiz-Argüelles A
Am J Clin Pathol; 1984 Mar; 81(3):414-5. PubMed ID: 6367421
[No Abstract] [Full Text] [Related]
49. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
[TBL] [Abstract][Full Text] [Related]
50. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
[TBL] [Abstract][Full Text] [Related]
51. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
[TBL] [Abstract][Full Text] [Related]
52. Longitudinal follow-up circulating immune complexes of the serum in patients with breast cancer.
Nekulová M; Tomanová J; Lang BA
Neoplasma; 1982; 29(5):573-7. PubMed ID: 7177247
[TBL] [Abstract][Full Text] [Related]
53. Presence of fucolipid antigens with mono- and dimeric X determinant (Lex) in the circulating immune complexes of patients with adenocarcinoma.
Singhal AK; Singhal MC; Nudelman E; Hakomori S; Balint JP; Grant CK; Snyder HW
Cancer Res; 1987 Nov; 47(21):5566-71. PubMed ID: 2444333
[TBL] [Abstract][Full Text] [Related]
54. Failure to find C1q-binding material and anti-IgG antibodies in ankylosing spondylitis.
Duquesnoy B; Santoro F; Wattre P; Delcambre B
Ann Rheum Dis; 1980 Oct; 39(5):449-52. PubMed ID: 6969066
[TBL] [Abstract][Full Text] [Related]
55. Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer.
Herberman RB; Bordes M; Lambert PH; Luthra HS; Robins RA; Sizaret P; Theofilopoulos A
Int J Cancer; 1981 May; 27(5):569-76. PubMed ID: 7287224
[TBL] [Abstract][Full Text] [Related]
56. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
Wener MH; Mannik M; Schwartz MM; Lewis EJ
Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
[TBL] [Abstract][Full Text] [Related]
57. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
Agnello V; Mitamura T
Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
[TBL] [Abstract][Full Text] [Related]
58. A survey for circulating immune complexes in patients with acute myocardial infarction. Use of a C1q-binding assay with soluble protein A as indicator.
Farrell C; Bloth B; Nielsen H; Daugharty H; Lundman T; Svehag SE
Scand J Immunol; 1977; 6(12):1233-40. PubMed ID: 605362
[TBL] [Abstract][Full Text] [Related]
59. Immune complexes in breast cancer patients as detected by C1q binding.
Papsidero LD; Nemoto T; Snyderman MC; Chu TM
Cancer; 1979 Nov; 44(5):1636-40. PubMed ID: 498035
[TBL] [Abstract][Full Text] [Related]
60. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
